Epirus Biopharmaceuticals Overview

Life ScienceCompany

Was Epirus Biopharmaceuticals formerly PE-backed?

Yes. Epirus Biopharmaceuticals was formerly owned by 2 private investors.

Where is Epirus Biopharmaceuticals headquartered?

Epirus Biopharmaceuticals is headquartered in Boston, Massachusetts.

How many employees does Epirus Biopharmaceuticals have?

Epirus Biopharmaceuticals has 73 employees.

What sector is Epirus Biopharmaceuticals in?

Epirus Biopharmaceuticals is a life science company.

When was Epirus Biopharmaceuticals founded?

Epirus Biopharmaceuticals was founded in 2011.

Epirus Biopharmaceuticals

Epirus Biopharmaceuticals, Inc.

699 Boylston Street, 8th Floor,
Boston, Massachusetts 02116
United States,
(617) 600-3497
www.epirusbiopharma.com

Epirus Biopharmaceuticals is a biopharmaceutical company, develops, manufactures and commercializes biosimilar therapeutics worldwide. Epirus Biopharmaceuticals is based in Boston, Massachusetts.


M&A Summary

Buy vs Sell

Year '11 '12 '13 '14 '15 T
Buy (0.4/yr) # - - - 1 1 2
vol $14M $14M
Sell (0.2/yr) # - - - - 1 1
vol $4M $4M
  3

Top M&A Advisors

Financial Deals
Leerink Partners
1
Legal Deals
Latham & Watkins
1

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.